KRAS and colorectal carcinoma: Given that there are likely still numerous unexplored transporter alterations in CRC harboring KRAS mutation, we analyzed the transcript abundance of the transporters of glutaminolysis-associated metabolites in KRAS-mutant CRC tissues using publicly available data sets from The Cancer Genome Atlas (TCGA).